Dai ichi Life Insurance Company Ltd Has $2.08 Million Holdings in AMETEK, Inc. $AME

Dai ichi Life Insurance Company Ltd lessened its stake in shares of AMETEK, Inc. (NYSE:AMEFree Report) by 20.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,680 shares of the technology company’s stock after selling 2,500 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in AMETEK were worth $2,075,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Sivia Capital Partners LLC acquired a new stake in shares of AMETEK in the 2nd quarter valued at $295,000. Baird Financial Group Inc. grew its holdings in shares of AMETEK by 16.1% in the 2nd quarter. Baird Financial Group Inc. now owns 16,784 shares of the technology company’s stock worth $3,037,000 after purchasing an additional 2,323 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of AMETEK by 65.0% during the 2nd quarter. NewEdge Advisors LLC now owns 3,946 shares of the technology company’s stock worth $714,000 after purchasing an additional 1,555 shares in the last quarter. Sei Investments Co. lifted its holdings in AMETEK by 38.2% during the 2nd quarter. Sei Investments Co. now owns 223,227 shares of the technology company’s stock valued at $40,392,000 after purchasing an additional 61,672 shares during the last quarter. Finally, Squarepoint Ops LLC lifted its holdings in AMETEK by 105.3% during the 2nd quarter. Squarepoint Ops LLC now owns 158,274 shares of the technology company’s stock valued at $28,641,000 after purchasing an additional 81,178 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.

AMETEK Stock Up 0.1%

NYSE AME opened at $242.10 on Monday. The stock has a market capitalization of $55.49 billion, a P/E ratio of 36.57, a price-to-earnings-growth ratio of 3.39 and a beta of 0.99. AMETEK, Inc. has a 52 week low of $175.61 and a 52 week high of $244.71. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.72 and a current ratio of 1.14. The stock has a fifty day moving average of $231.91 and a 200-day moving average of $227.62.

AMETEK (NYSE:AMEGet Free Report) last issued its quarterly earnings results on Thursday, April 30th. The technology company reported $1.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.07. The business had revenue of $1.93 billion for the quarter, compared to analyst estimates of $1.91 billion. AMETEK had a return on equity of 16.63% and a net margin of 20.11%.The firm’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.75 earnings per share. AMETEK has set its FY 2026 guidance at 7.940-8.140 EPS and its Q2 2026 guidance at 1.960-2.000 EPS. On average, equities research analysts forecast that AMETEK, Inc. will post 8.14 EPS for the current year.

AMETEK Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th were given a dividend of $0.34 per share. The ex-dividend date was Monday, June 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.6%. AMETEK’s dividend payout ratio is presently 20.54%.

Wall Street Analyst Weigh In

A number of research firms have commented on AME. Barclays boosted their price target on shares of AMETEK from $220.00 to $230.00 and gave the company an “equal weight” rating in a research report on Monday, May 4th. Royal Bank Of Canada lifted their target price on shares of AMETEK from $259.00 to $260.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Truist Financial boosted their target price on AMETEK from $275.00 to $303.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. Citigroup initiated coverage on AMETEK in a research report on Monday, June 15th. They set a “neutral” rating and a $257.00 price target on the stock. Finally, Rothschild & Co Redburn set a $265.00 price target on AMETEK in a report on Thursday, June 18th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, AMETEK presently has an average rating of “Moderate Buy” and a consensus price target of $256.29.

View Our Latest Research Report on AME

About AMETEK

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

See Also

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.